对-227向辐射治疗的双功能化剂的合成和评估
Joshua J Woods1, Alex Rigby1, Jennifer N Wacker1
1Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Journal of medicinal chemistry
|January 3, 2025
概括
一种新的双功能化剂,p-SCN-Bn-DOTHOPO,简化了使用-227 (227Th) 的化治疗剂的合成. 这种新型化剂还可以使用-89 (89Zr) 进行成像应用.
科学领域:
- 放射化学 放射化学是指辐射化学.
- 核医学是一种核医学.
- 免疫结合体的发展
背景情况:
- -227 (227Th) 是针对性阿尔法疗法的有前途的阿尔法发射体.
- 现有的227Th化剂需要复杂的,多步骤的合成.
- 开发高效的化剂对于推进基于227Th的放射性药物至关重要.
研究的目的:
- 为了合成和评估一个新的双功能化剂,p-SCN-Bn-DOTHOPO,为227Th和89Zr.
- 为了将化剂与向抗体 (trastuzumab) 相结合.
- 评估产生的免疫结合物的放射标记效率,纯度和稳定性.
主要方法:
- 通过四步过程合成p-SCN-Bn-DOTHOPO.
- 化剂的结合与特拉斯图祖马布.
- 用227Th和89Zr进行放射性标记.
- 评估放射性化学产量,纯度和生物稳定性.
主要成果:
- 新型双功能化剂p-SCN-Bn-DOTHOPO的合成总产量为26%.
- 免疫结合物被有效地标记为227Th (≥95%的产量和纯度) 和89Zr.
- 放射性金属复合物表现出良好的生物稳定性.
结论:
- p-SCN-Bn-DOTHOPO为开发227Th和89Zr放射性药物提供了一种简化方法.
- 这种化剂有助于创建下一代向阿尔法疗法和PET成像剂.
- 这些发现为放射性金属复合的化器设计提供了宝贵的见解.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...


